메뉴 건너뛰기




Volumn 52, Issue 1, 2001, Pages 1-7

Learning from previous responses in phase I dose-escalation studies

Author keywords

Clinical trials; Continual reassessment method; Dose finding; First in man

Indexed keywords

ANTINEOPLASTIC AGENT; QUERCETIN;

EID: 0034832384     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2001.01383.x     Document Type: Review
Times cited : (18)

References (24)
  • 23
    • 0031953966 scopus 로고    scopus 로고
    • A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials
    • (1998) Biometrics , vol.54 , pp. 251-264
    • Thall, P.F.1    Russell, K.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.